High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-30

AUTHORS

Zeya Yan, Wei Wang, Xinyu Tao, Wei Cheng, Gang Zuo, Zhouqing Chen, Zhong Wang, Gang Chen

ABSTRACT

BackgroundLevodopa is the most commonly used first-line drug for Parkinson’s disease. However, during the period of medication, the generation of motor fluctuations affects the life quality of patients. CVT-301, as an inhaled levodopa for the treatment of OFF episodes, rose in response to this condition.MethodsWe systematically searched Medline, EMBASE, Cochrane Library, and Clinicaltrials.gov for relevant randomized controlled trials, from the earliest available date to February 12, 2022, to evaluate the efficacy of high and low dose of inhaled levodopa in patients with Parkinson’s disease.ResultsA total of six multicenter, randomized controlled trials with 1166 patients were included. Compared with placebo, CVT-301 has a statistically significant effect on the treatment of Parkinson’s patients with OFF episodes of medication interval. The UPDRS Part III score decreased more significantly in the high-dose group 30 minutes after administration than the low-dose group (WMD = − 4.51; 95% CI, − 7.34 to − 1.68; p = 0.002). More patients in the high-dose group achieved and maintained an on state up to 60 min after receiving study medication (RR = 1.17; 95% CI, 1.08 to 1.27; p < 0.001). And more patients were proved with improved PGIC scores in the high-dose group (RR = 1.13; 95% CI, 1.05 to 1.21; p = 0.001).ConclusionsHigh doses CVT-301 can improve the motor function of the patient to some extent. There seems no risk of increasing adverse reactions. More... »

PAGES

1-9

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10072-022-06298-z

DOI

http://dx.doi.org/10.1007/s10072-022-06298-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149869678

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35907110


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yan", 
        "givenName": "Zeya", 
        "id": "sg:person.014520436025.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014520436025.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, The First People\u2019s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.263761.7", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
            "Department of Neurosurgery, The First People\u2019s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Wei", 
        "id": "sg:person.010622570127.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010622570127.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tao", 
        "givenName": "Xinyu", 
        "id": "sg:person.015346020046.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015346020046.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "Wei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, The First People\u2019s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.263761.7", 
          "name": [
            "Department of Neurosurgery, The First People\u2019s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zuo", 
        "givenName": "Gang", 
        "id": "sg:person.0603016301.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603016301.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Zhouqing", 
        "id": "sg:person.01260307201.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260307201.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Zhong", 
        "id": "sg:person.0753556553.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753556553.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China", 
          "id": "http://www.grid.ac/institutes/grid.429222.d", 
          "name": [
            "Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Gang", 
        "id": "sg:person.0645055334.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645055334.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00415-020-09810-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126912616", 
          "https://doi.org/10.1007/s00415-020-09810-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200645020-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043255913", 
          "https://doi.org/10.2165/00003088-200645020-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40265-015-0377-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051943227", 
          "https://doi.org/10.1007/s40265-015-0377-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-019-09320-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113833746", 
          "https://doi.org/10.1007/s00415-019-09320-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40263-020-00769-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132299441", 
          "https://doi.org/10.1007/s40263-020-00769-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-020-10222-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1130872428", 
          "https://doi.org/10.1007/s00415-020-10222-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40265-020-01307-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126863420", 
          "https://doi.org/10.1007/s40265-020-01307-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-30", 
    "datePublishedReg": "2022-07-30", 
    "description": "BackgroundLevodopa is the most commonly used first-line drug for Parkinson\u2019s disease. However, during the period of medication, the generation of motor fluctuations affects the life quality of patients. CVT-301, as an inhaled levodopa for the treatment of OFF episodes, rose in response to this condition.MethodsWe systematically searched Medline, EMBASE, Cochrane Library, and Clinicaltrials.gov for relevant randomized controlled trials, from the earliest available date to February 12, 2022, to evaluate the efficacy of high and low dose of inhaled levodopa in patients with Parkinson\u2019s disease.ResultsA total of six multicenter, randomized controlled trials with 1166 patients were included. Compared with placebo, CVT-301 has a statistically significant effect on the treatment of Parkinson\u2019s patients with OFF episodes of medication interval. The UPDRS Part III score decreased more significantly in the high-dose group 30\u00a0minutes after administration than the low-dose group (WMD\u2009=\u2009\u2009\u2212\u20094.51; 95% CI,\u2009\u2212\u20097.34 to\u2009\u2212\u20091.68; p\u2009=\u20090.002). More patients in the high-dose group achieved and maintained an on state up to 60\u00a0min after receiving study medication (RR\u2009=\u20091.17; 95% CI, 1.08 to 1.27; p\u2009<\u20090.001). And more patients were proved with improved PGIC scores in the high-dose group (RR\u2009=\u20091.13; 95% CI, 1.05 to 1.21; p\u2009=\u20090.001).ConclusionsHigh doses CVT-301 can improve the motor function of the patient to some extent. There seems no risk of increasing adverse reactions.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10072-022-06298-z", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294956", 
        "issn": [
          "1590-1874", 
          "1126-5442"
        ], 
        "name": "Neurological Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "high-dose group", 
      "CVT-301", 
      "OFF episodes", 
      "Parkinson's disease", 
      "more patients", 
      "UPDRS part III score", 
      "low-dose group", 
      "period of medication", 
      "part III score", 
      "first-line drugs", 
      "earliest available date", 
      "medication interval", 
      "study medication", 
      "PGIC scores", 
      "motor fluctuations", 
      "Cochrane Library", 
      "ResultsA total", 
      "adverse reactions", 
      "motor function", 
      "group 30", 
      "low dose", 
      "patients", 
      "Parkinson's patients", 
      "disease", 
      "levodopa", 
      "trials", 
      "medications", 
      "life quality", 
      "available date", 
      "treatment", 
      "episodes", 
      "dose", 
      "scores", 
      "group", 
      "multicenter", 
      "placebo", 
      "EMBASE", 
      "MEDLINE", 
      "MethodsWe", 
      "administration", 
      "drugs", 
      "efficacy", 
      "significant effect", 
      "total", 
      "risk", 
      "minutes", 
      "ConclusionsHigh", 
      "min", 
      "response", 
      "interval", 
      "period", 
      "date", 
      "effect", 
      "function", 
      "extent", 
      "quality", 
      "library", 
      "reaction", 
      "conditions", 
      "state", 
      "generation", 
      "fluctuations"
    ], 
    "name": "High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials", 
    "pagination": "1-9", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149869678"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10072-022-06298-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35907110"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10072-022-06298-z", 
      "https://app.dimensions.ai/details/publication/pub.1149869678"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_950.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10072-022-06298-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-022-06298-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-022-06298-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-022-06298-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-022-06298-z'


 

This table displays all metadata directly associated to this object as RDF triples.

197 TRIPLES      21 PREDICATES      92 URIs      77 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10072-022-06298-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nbfa4c5f8f5b44303a8252f8f8d937479
4 schema:citation sg:pub.10.1007/s00415-019-09320-1
5 sg:pub.10.1007/s00415-020-09810-7
6 sg:pub.10.1007/s00415-020-10222-w
7 sg:pub.10.1007/s40263-020-00769-7
8 sg:pub.10.1007/s40265-015-0377-y
9 sg:pub.10.1007/s40265-020-01307-x
10 sg:pub.10.2165/00003088-200645020-00001
11 schema:datePublished 2022-07-30
12 schema:datePublishedReg 2022-07-30
13 schema:description BackgroundLevodopa is the most commonly used first-line drug for Parkinson’s disease. However, during the period of medication, the generation of motor fluctuations affects the life quality of patients. CVT-301, as an inhaled levodopa for the treatment of OFF episodes, rose in response to this condition.MethodsWe systematically searched Medline, EMBASE, Cochrane Library, and Clinicaltrials.gov for relevant randomized controlled trials, from the earliest available date to February 12, 2022, to evaluate the efficacy of high and low dose of inhaled levodopa in patients with Parkinson’s disease.ResultsA total of six multicenter, randomized controlled trials with 1166 patients were included. Compared with placebo, CVT-301 has a statistically significant effect on the treatment of Parkinson’s patients with OFF episodes of medication interval. The UPDRS Part III score decreased more significantly in the high-dose group 30 minutes after administration than the low-dose group (WMD =  − 4.51; 95% CI, − 7.34 to − 1.68; p = 0.002). More patients in the high-dose group achieved and maintained an on state up to 60 min after receiving study medication (RR = 1.17; 95% CI, 1.08 to 1.27; p < 0.001). And more patients were proved with improved PGIC scores in the high-dose group (RR = 1.13; 95% CI, 1.05 to 1.21; p = 0.001).ConclusionsHigh doses CVT-301 can improve the motor function of the patient to some extent. There seems no risk of increasing adverse reactions.
14 schema:genre article
15 schema:isAccessibleForFree false
16 schema:isPartOf sg:journal.1294956
17 schema:keywords CVT-301
18 Cochrane Library
19 ConclusionsHigh
20 EMBASE
21 MEDLINE
22 MethodsWe
23 OFF episodes
24 PGIC scores
25 Parkinson's disease
26 Parkinson's patients
27 ResultsA total
28 UPDRS part III score
29 administration
30 adverse reactions
31 available date
32 conditions
33 date
34 disease
35 dose
36 drugs
37 earliest available date
38 effect
39 efficacy
40 episodes
41 extent
42 first-line drugs
43 fluctuations
44 function
45 generation
46 group
47 group 30
48 high-dose group
49 interval
50 levodopa
51 library
52 life quality
53 low dose
54 low-dose group
55 medication interval
56 medications
57 min
58 minutes
59 more patients
60 motor fluctuations
61 motor function
62 multicenter
63 part III score
64 patients
65 period
66 period of medication
67 placebo
68 quality
69 reaction
70 response
71 risk
72 scores
73 significant effect
74 state
75 study medication
76 total
77 treatment
78 trials
79 schema:name High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials
80 schema:pagination 1-9
81 schema:productId N6c349c3a99d648a9abb1e8122e29132d
82 Nc551ee4b5fae41c98793df8a7430d07a
83 Ne928e49e5ebd4b29a763fe8776d86a54
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149869678
85 https://doi.org/10.1007/s10072-022-06298-z
86 schema:sdDatePublished 2022-09-02T16:08
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N1128e03f69bd48969791dd3e1e0cc1e9
89 schema:url https://doi.org/10.1007/s10072-022-06298-z
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N1128e03f69bd48969791dd3e1e0cc1e9 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N1a0c5525630e453283bb4ae8905c90dc rdf:first Nfdea3e48b8894a6d9f96cb1066931551
96 rdf:rest N910c3fd4b70647a8908be00b0376bb22
97 N6361a0930cec45b9b611ad0a5542fe00 rdf:first sg:person.010622570127.23
98 rdf:rest Nff1d117694c4472ca013d29b451c63dc
99 N6bd72a9d5ad14485b1e0c653cc940e36 rdf:first sg:person.01260307201.78
100 rdf:rest Ndb939224d7fe42a1a7c9f0685d08a12d
101 N6c349c3a99d648a9abb1e8122e29132d schema:name doi
102 schema:value 10.1007/s10072-022-06298-z
103 rdf:type schema:PropertyValue
104 N910c3fd4b70647a8908be00b0376bb22 rdf:first sg:person.0603016301.24
105 rdf:rest N6bd72a9d5ad14485b1e0c653cc940e36
106 N9bb36533b6124627b90a39fd16a2f2c2 rdf:first sg:person.0645055334.34
107 rdf:rest rdf:nil
108 Nbfa4c5f8f5b44303a8252f8f8d937479 rdf:first sg:person.014520436025.43
109 rdf:rest N6361a0930cec45b9b611ad0a5542fe00
110 Nc551ee4b5fae41c98793df8a7430d07a schema:name dimensions_id
111 schema:value pub.1149869678
112 rdf:type schema:PropertyValue
113 Ndb939224d7fe42a1a7c9f0685d08a12d rdf:first sg:person.0753556553.56
114 rdf:rest N9bb36533b6124627b90a39fd16a2f2c2
115 Ne928e49e5ebd4b29a763fe8776d86a54 schema:name pubmed_id
116 schema:value 35907110
117 rdf:type schema:PropertyValue
118 Nfdea3e48b8894a6d9f96cb1066931551 schema:affiliation grid-institutes:grid.429222.d
119 schema:familyName Cheng
120 schema:givenName Wei
121 rdf:type schema:Person
122 Nff1d117694c4472ca013d29b451c63dc rdf:first sg:person.015346020046.66
123 rdf:rest N1a0c5525630e453283bb4ae8905c90dc
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
128 schema:name Clinical Sciences
129 rdf:type schema:DefinedTerm
130 sg:journal.1294956 schema:issn 1126-5442
131 1590-1874
132 schema:name Neurological Sciences
133 schema:publisher Springer Nature
134 rdf:type schema:Periodical
135 sg:person.010622570127.23 schema:affiliation grid-institutes:grid.263761.7
136 schema:familyName Wang
137 schema:givenName Wei
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010622570127.23
139 rdf:type schema:Person
140 sg:person.01260307201.78 schema:affiliation grid-institutes:grid.429222.d
141 schema:familyName Chen
142 schema:givenName Zhouqing
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260307201.78
144 rdf:type schema:Person
145 sg:person.014520436025.43 schema:affiliation grid-institutes:grid.429222.d
146 schema:familyName Yan
147 schema:givenName Zeya
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014520436025.43
149 rdf:type schema:Person
150 sg:person.015346020046.66 schema:affiliation grid-institutes:grid.429222.d
151 schema:familyName Tao
152 schema:givenName Xinyu
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015346020046.66
154 rdf:type schema:Person
155 sg:person.0603016301.24 schema:affiliation grid-institutes:grid.263761.7
156 schema:familyName Zuo
157 schema:givenName Gang
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603016301.24
159 rdf:type schema:Person
160 sg:person.0645055334.34 schema:affiliation grid-institutes:grid.429222.d
161 schema:familyName Chen
162 schema:givenName Gang
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645055334.34
164 rdf:type schema:Person
165 sg:person.0753556553.56 schema:affiliation grid-institutes:grid.429222.d
166 schema:familyName Wang
167 schema:givenName Zhong
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753556553.56
169 rdf:type schema:Person
170 sg:pub.10.1007/s00415-019-09320-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113833746
171 https://doi.org/10.1007/s00415-019-09320-1
172 rdf:type schema:CreativeWork
173 sg:pub.10.1007/s00415-020-09810-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1126912616
174 https://doi.org/10.1007/s00415-020-09810-7
175 rdf:type schema:CreativeWork
176 sg:pub.10.1007/s00415-020-10222-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1130872428
177 https://doi.org/10.1007/s00415-020-10222-w
178 rdf:type schema:CreativeWork
179 sg:pub.10.1007/s40263-020-00769-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132299441
180 https://doi.org/10.1007/s40263-020-00769-7
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/s40265-015-0377-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051943227
183 https://doi.org/10.1007/s40265-015-0377-y
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/s40265-020-01307-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1126863420
186 https://doi.org/10.1007/s40265-020-01307-x
187 rdf:type schema:CreativeWork
188 sg:pub.10.2165/00003088-200645020-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043255913
189 https://doi.org/10.2165/00003088-200645020-00001
190 rdf:type schema:CreativeWork
191 grid-institutes:grid.263761.7 schema:alternateName Department of Neurosurgery, The First People’s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China
192 schema:name Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China
193 Department of Neurosurgery, The First People’s Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, 215400, Suzhou, Jiangsu Province, China
194 rdf:type schema:Organization
195 grid-institutes:grid.429222.d schema:alternateName Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China
196 schema:name Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, 215006, Suzhou, Jiangsu Province, China
197 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...